Tasly Delivers Profit Growth on Flat Revenue, Bolstering China Resources PharmaceuticalTip Ranks·Jul 14 at 07:08 AM03320+1.44%600535+0.20%
Heart Drug Sales Soar in China After Education Guru Zhang Xuefeng Dies SuddenlyYicai·Mar 27 at 07:20 AM600535+0.20%
CHINARES PHARMA subsidiary TASLY earned 1.105 billion RMB for the year, an increase of 15.6%AASTOCKS·Mar 19 at 09:32 AM513700+0.79%513060+1.05%
China Resources Pharmaceutical's subsidiary TASLY earned 1.105 billion RMB last year, an increase of 15.7%AASTOCKS·Feb 8 at 04:35 AM600535+0.20%159929-0.43%
With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's "Special Regulations on the Registration of Traditional Chinese Medicine" is entering its final window period. This regulation, referred to in the industry as the "death clause" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibitedWallstreetcn·Jan 27 at 04:41 AM512290-0.82%159929-0.43%
19:00 ET Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standardprnewswire·Jan 25 at 06:03 PM600535+0.20%
Tasly Pharmaceutical’s Nine-Month Financials Show Increased ProfitTip Ranks·Oct 24, 2025 at 04:42 AM600535+0.20%
TASLY: The net profit for the third quarter was 210 million yuan, a year-on-year increase of 16.56%Zhitong·Oct 24, 2025 at 03:59 AM600535+0.20%
TASLY: The company's medicine Wenjing Decoction Granules has obtained a drug registration certificateZhitong·Oct 13, 2025 at 04:12 AM600535+0.20%
TASLY's subsidiary has received a drug registration certificate for the new indication of recombinant human urokinase injection in acute ischemic strokeZhitong·Sep 22, 2025 at 03:23 AM600535+0.20%
TASLY released its semi-annual performance, with a net profit attributable to the parent company of 775 million yuan, a year-on-year increase of 16.97%Zhitong·Aug 15, 2025 at 05:24 AM600535+0.20%
ZJJF and others invest in Hainan to establish a cell biotechnology companyZhitong·Jul 22, 2025 at 10:46 PM600668-0.66%600535+0.20%
TASLY: The registration application for Loquat Lung Cleansing Granules has been withdrawnZhitong·Jul 18, 2025 at 04:19 AM600535+0.20%
